NYSE:SEM - Select Medical Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $37.00
  • Forecasted Upside: 48.71 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$24.88
▼ -0.83 (-3.23%)

This chart shows the closing price for SEM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Select Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SEM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SEM

Analyst Price Target is $37.00
▲ +48.71% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Select Medical in the last 3 months. The average price target is $37.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 48.71% upside from the last price of $24.88.

This chart shows the closing price for SEM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 3 polled investment analysts is to buy stock in Select Medical. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/12/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/12/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/11/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/9/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/7/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/7/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/6/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/6/2022

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/17/2022Credit Suisse GroupLower Price TargetNeutral$27.00Low
3/16/2022Credit Suisse GroupLower Price TargetNeutral$37.00 ➝ $28.00Medium
3/7/2022Royal Bank of CanadaLower Price TargetOutperform$47.00 ➝ $42.00Medium
1/19/2022Deutsche Bank AktiengesellschaftLower Price Target$48.00 ➝ $44.00High
1/18/2022Bank of AmericaLower Price TargetBuy$40.00 ➝ $35.00High
1/18/2022Royal Bank of CanadaLower Price TargetOutperform$50.00 ➝ $47.00High
8/10/2021Credit Suisse GroupBoost Price TargetNeutral$37.00 ➝ $39.00Low
6/23/2021BenchmarkBoost Price TargetBuy$44.00 ➝ $50.00Medium
5/17/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$42.00 ➝ $46.00Medium
5/13/2021BenchmarkBoost Price TargetBuy$40.00 ➝ $44.00High
5/10/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$42.00 ➝ $46.00Medium
3/1/2021Credit Suisse GroupBoost Price TargetNeutral$32.00 ➝ $34.00Low
2/26/2021Bank of AmericaUpgradeUnderperform ➝ Buy$30.00 ➝ $36.00High
2/17/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$27.00 ➝ $34.00Low
1/5/2021Credit Suisse GroupBoost Price TargetNeutral$22.00 ➝ $27.00N/A
11/2/2020Credit Suisse GroupBoost Price TargetNeutral$19.00 ➝ $22.00High
8/4/2020Deutsche Bank AktiengesellschaftBoost Price TargetPositive ➝ Buy$24.00 ➝ $26.00Low
8/3/2020Credit Suisse GroupBoost Price TargetNeutral$18.00 ➝ $19.00Low
6/16/2020Bank of AmericaDowngradeNeutral ➝ Underperform$18.00 ➝ $15.00High
5/4/2020Credit Suisse GroupLower Price TargetNeutral$23.00 ➝ $18.00Low
5/4/2020Wells Fargo & CompanyLower Price TargetOverweight$31.00 ➝ $24.00High
4/24/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$33.00 ➝ $24.00High
4/20/2020Royal Bank of CanadaReiterated RatingBuy$26.00Low
4/3/2020Credit Suisse GroupLower Price TargetNeutral$29.00 ➝ $23.00High
3/24/2020BenchmarkLower Price TargetBuy$33.00 ➝ $25.00High
2/24/2020Royal Bank of CanadaReiterated RatingOutperform ➝ Positive$32.00High
2/24/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$22.00 ➝ $33.00High
1/28/2020Royal Bank of CanadaReiterated RatingOutperform$27.00High
11/1/2019Credit Suisse GroupSet Price TargetHold$18.00High
9/16/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy$22.00Low
5/17/2019JMP SecuritiesUpgradeMarket Perform ➝ Outperform$18.00Medium
5/9/2019BarclaysReiterated RatingHold$16.00Low
1/7/2019Credit Suisse GroupLower Price TargetNeutral ➝ Neutral$21.00 ➝ $16.00High
12/14/2018BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$20.00High
11/5/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$18.00 ➝ $21.00Medium
10/16/2018Credit Suisse GroupInitiated CoverageNeutral ➝ Neutral$18.00Medium
2/27/2018JMP SecuritiesUpgradeUnderperform ➝ Market Perform$12.00Low
2/23/2018Robert W. BairdReiterated RatingBuy$26.00Low
1/30/2018Wells Fargo & CompanyInitiated CoverageOutperform ➝ Outperform$26.00High
1/4/2018Bank of AmericaUpgradeUnderperform ➝ Neutral$19.00Medium
11/6/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$22.00N/A
10/23/2017Robert W. BairdSet Price TargetBuy$25.00N/A
10/17/2017Robert W. BairdReiterated RatingBuy$21.00N/A
10/13/2017Royal Bank of CanadaReiterated RatingBuy$19.00N/A
9/13/2017Royal Bank of CanadaReiterated RatingBuy$19.00Low
8/7/2017JMP SecuritiesBoost Price TargetMarket Underperform$10.00 ➝ $12.00High
8/7/2017Deutsche Bank AktiengesellschaftBoost Price TargetHold$20.00 ➝ $22.00Low
8/7/2017BenchmarkBoost Price TargetBuy ➝ Buy$17.00 ➝ $20.00High
8/7/2017Robert W. BairdUpgradeNeutral ➝ Outperform$15.00 ➝ $21.00High
(Data available from 7/6/2017 forward)

News Sentiment Rating

0.25 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/8/2021
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/7/2022
  • 2 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
2/6/2022
  • 0 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/8/2022
  • 1 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
4/7/2022
  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/7/2022
  • 1 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/6/2022
  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
7/6/2022

Current Sentiment

  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
Select Medical logo
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. Its Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The company's Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. Its Concentra segment operates and provides occupational health centers and contract services at employer worksites that deliver occupational medicine, consumer health, physical therapy, and wellness services. As of December 31, 2021, the company operated 104 critical illness recovery hospitals in 28 states; 30 rehabilitation hospitals in 12 states; 1,881 outpatient rehabilitation clinics in 38 states and the District of Columbia; and 518 occupational health centers in 41 states, and 134 onsite clinics at employer worksites states. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.
Read More

Today's Range

Now: $24.88
Low: $24.66
High: $25.49

50 Day Range

MA: $23.86
Low: $21.66
High: $25.80

52 Week Range

Now: $24.88
Low: $21.40
High: $42.72

Volume

7,266 shs

Average Volume

872,888 shs

Market Capitalization

$3.25 billion

P/E Ratio

10.16

Dividend Yield

1.99%

Beta

1.24

Frequently Asked Questions

What sell-side analysts currently cover shares of Select Medical?

The following Wall Street sell-side analysts have issued reports on Select Medical in the last twelve months: Bank of America Co., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Royal Bank of Canada, and StockNews.com.
View the latest analyst ratings for SEM.

What is the current price target for Select Medical?

0 Wall Street analysts have set twelve-month price targets for Select Medical in the last year. Their average twelve-month price target is $37.00, suggesting a possible upside of 48.7%.
View the latest price targets for SEM.

What is the current consensus analyst rating for Select Medical?

Select Medical currently has 1 hold rating and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SEM will outperform the market and that investors should add to their positions of Select Medical.
View the latest ratings for SEM.

How do I contact Select Medical's investor relations team?

Select Medical's physical mailing address is 4714 GETTYSBURG ROAD P.O. BOX 2034, MECHANICSBURG PA, 17055. The health services provider's listed phone number is (888) 735-6332 and its investor relations email address is [email protected] The official website for Select Medical is www.selectmedicalcorp.com. Learn More about contacing Select Medical investor relations.